| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19,479 |
16,999 |
$1.04M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,860 |
16,784 |
$1.03M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
30,440 |
13,879 |
$449K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,605 |
8,909 |
$391K |
| S8301 |
Infection control supplies, not otherwise specified |
13,523 |
11,307 |
$373K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,698 |
3,618 |
$348K |
| 86328 |
|
7,922 |
6,755 |
$344K |
| 94010 |
|
12,726 |
11,235 |
$341K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,919 |
2,825 |
$293K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,103 |
2,902 |
$274K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15,169 |
13,793 |
$223K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,828 |
8,074 |
$171K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,808 |
1,611 |
$153K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,183 |
7,679 |
$129K |
| 99429 |
|
2,562 |
2,365 |
$91K |
| 99406 |
|
5,432 |
4,712 |
$57K |
| 92551 |
|
5,671 |
5,105 |
$53K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
468 |
442 |
$43K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,874 |
2,931 |
$35K |
| 87807 |
|
2,660 |
2,328 |
$30K |
| 94060 |
|
449 |
413 |
$21K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,245 |
1,141 |
$17K |
| 94760 |
|
10,677 |
8,967 |
$17K |
| 90461 |
|
2,077 |
1,568 |
$13K |
| 99000 |
|
1,030 |
1,001 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,537 |
7,132 |
$8K |
| G0402 |
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment |
292 |
290 |
$7K |
| 99381 |
|
57 |
52 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
630 |
610 |
$3K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
829 |
808 |
$2K |
| 96160 |
|
885 |
846 |
$2K |
| 99215 |
Prolong outpt/office vis |
13 |
13 |
$1K |
| 96161 |
|
272 |
262 |
$635.98 |
| 81025 |
|
37 |
35 |
$276.06 |
| CP002 |
|
26 |
14 |
$212.98 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
56 |
52 |
$104.46 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
316 |
307 |
$87.56 |
| 81002 |
|
12 |
12 |
$32.35 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
15 |
15 |
$32.00 |
| 90686 |
|
3,991 |
3,932 |
$0.73 |
| 90651 |
|
1,006 |
995 |
$0.07 |
| 90620 |
|
854 |
844 |
$0.05 |
| 90619 |
|
354 |
354 |
$0.05 |
| 90677 |
|
306 |
303 |
$0.04 |
| 90680 |
|
866 |
847 |
$0.00 |
| 90723 |
|
406 |
397 |
$0.00 |
| 36416 |
|
1,040 |
1,007 |
$0.00 |
| 90696 |
|
138 |
135 |
$0.00 |
| 90698 |
|
40 |
38 |
$0.00 |
| 90674 |
|
31 |
30 |
$0.00 |
| 90633 |
|
712 |
693 |
$0.00 |
| 90710 |
|
689 |
684 |
$0.00 |
| 90648 |
|
1,039 |
1,026 |
$0.00 |
| 90715 |
|
94 |
92 |
$0.00 |
| 90670 |
|
1,121 |
1,105 |
$0.00 |
| 90734 |
|
462 |
447 |
$0.00 |
| 90700 |
|
105 |
104 |
$0.00 |
| 90685 |
|
43 |
43 |
$0.00 |